Another research also reports that non-autologous exosomes can deliver CRISPR/Cas9 plasmid DNA which targets the mutant Kras G12D into recipient pancreatic cancer cells in syngeneic subcutaneous and orthotopic models and suppresses proliferation and tumor growth in these models 42. This evidence concerns the gene KRAS and familial pancreatic carcinoma.